Modified-release topical hydrogels: A ten-year review

FM Croisfelt, LL Tundisi, JA Ataide, E Silveira… - Journal of materials …, 2019 - Springer
Hydrogels are polymeric networks with tridimensional structure, which are able to load water
and other substances. Such property makes hydrogels suitable for innumerous applications …

Efficacy and safety of antibiotic agents in the treatment of rosacea: a systemic network meta-analysis

W **ao, M Chen, B Wang, Y Huang, Z Zhao… - Frontiers in …, 2023 - frontiersin.org
Background: Antibiotics are considered the backbone of rosacea management, especially
for controlling inflammatory papules and pustules. We aim to evaluate the efficacy and safety …

A gold-based immunochromatographic strip for the specific detection of tacrolimus in whole blood

X Jiang, X Xu, H Kuang, L Liu, L Xu, A Qu… - Journal of Materials …, 2023 - pubs.rsc.org
Tacrolimus is a macrolide immunosuppressant widely used in organ transplantation. Due to
the narrow treatment window, therapeutic drug monitoring of the clinical application of …

Improved topical delivery of tacrolimus: a novel composite hydrogel formulation for the treatment of psoriasis

D Gabriel, T Mugnier, H Courthion, K Kranidioti… - Journal of Controlled …, 2016 - Elsevier
We have developed a composite hydrogel for improved topical delivery of the poorly soluble
drug Tacrolimus (TAC) to psoriasis lesions. TAC is efficiently solubilized in methoxy poly …

Tacrolimus nanoparticles based on chitosan combined with nicotinamide: enhancing percutaneous delivery and treatment efficacy for atopic dermatitis and reducing …

K Yu, Y Wang, T Wan, Y Zhai, S Cao… - International Journal …, 2018 - Taylor & Francis
Background Topical application of tacrolimus (FK506) was effective in the treatment of atopic
dermatitis (AD); however, adverse effects frequently occurred with the increase of FK506 …

Efficacy and safety of low-dose topical tacrolimus in vernal keratoconjunctivitis

SS Shoughy, MO Jaroudi, KF Tabbara - Clinical Ophthalmology, 2016 - Taylor & Francis
Objective The objective of this study was to evaluate the efficacy and safety of topical low-
dose tacrolimus (0.01%) solution in patients with vernal keratoconjunctivitis (VKC). Patients …

Advances in Treatments for Epidermolysis Bullosa (EB): emphasis on Stem Cell-Based Therapy

R Raoufinia, H Rahimi, N Keyhanvar… - Stem Cell Reviews and …, 2024 - Springer
Epidermolysis bullosa (EB) is a rare genetic dermatosis characterized by skin fragility and
blister formation. With a wide phenotypic spectrum and potential extracutaneous …

Tacrolimus 0.1% versus ciclopiroxolamine 1% for maintenance therapy in patients with severe facial seborrheic dermatitis: a multicenter, double-blind, randomized …

P Joly, I Tejedor, F Tetart, HC Cailleux, A Barrel… - Journal of the American …, 2021 - Elsevier
Background No long-term maintenance therapy has been tested in patients with seborrheic
dermatitis (SD). Objective We sought to compare the efficacy and tolerance of tacrolimus …

Development and evaluation of tacrolimus loaded nano-transferosomes for skin targeting and dermatitis treatment

J Ren, T Liu, B Bi, S Sohail, F ud Din - Journal of Pharmaceutical Sciences, 2024 - Elsevier
Tacrolimus (TRL) is used for the treatment of atopic dermatitis (AD) due to its T-cell
stimulation effect. However, its significantly poor water solubility, low penetration and …

Atopic dermatitis treatment: A comprehensive review of conventional and novel bioengineered approaches

N Elahi, ME Astaneh, J Ai, M Rizwan - International Journal of Biological …, 2024 - Elsevier
Atopic dermatitis (AD) remains a challenging condition, with conventional treatments often
leading to adverse effects and limited efficacy. This review explores the diverse landscape of …